In the past three weeks, a flurry of licensing deals with Chinese biotechs were announced featuring AbbVie, AstraZeneca, ...
Former chemistry teacher Zhong Huijan’s Hansoh Pharmaceutical Group strikes potentially lucrative licensing deals with big pharma players, giving her a wealth boost. China’s growing pipeline of ...
The United States is at risk of losing one of the most important technology races of the 21st century: biotechnology. A 2025 report from a bipartisan, congressionally chartered commission warns that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback